<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36550502</PMID><DateCompleted><Year>2022</Year><Month>12</Month><Day>26</Day></DateCompleted><DateRevised><Year>2023</Year><Month>01</Month><Day>24</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1743-422X</ISSN><JournalIssue CitedMedium="Internet"><Volume>19</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Dec</Month><Day>22</Day></PubDate></JournalIssue><Title>Virology journal</Title><ISOAbbreviation>Virol J</ISOAbbreviation></Journal><ArticleTitle>ADAR1p110 promotes Enterovirus D68 replication through its deaminase domain and inhibition of PKR pathway.</ArticleTitle><Pagination><StartPage>222</StartPage><MedlinePgn>222</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">222</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12985-022-01952-6</ELocationID><Abstract><AbstractText Label="BACKGROUND">Severe respiratory and neurological diseases caused by human enterovirus D68 (EV-D68) pose a serious threat to public health, and there are currently no effective drugs and vaccines. Adenosine deaminase acting on RNA1 (ADAR1) has diverse biological functions in various viral infections, but its role in EV-D68 infections remains undetermined.</AbstractText><AbstractText Label="METHODS">Rhabdomyosarcoma (RD) and human embryonic kidney 293&#xa0;T (293&#xa0;T) cells, and HeLa cells were used to evaluate the expression level of ADAR1 upon EV-D68 (Fermon strain) and human parainfluenza virus type 3 (HPIV3; NIH47885) infection, respectively. Knockdown through silencing RNA (siRNA) and overexpression of either ADAR1p110 or ADAR1p150 in cells were used to determine the function of the two proteins after viral infection. ADAR1p110 double-stranded&#xa0;RNA&#xa0;binding&#xa0;domains (dsRBDs) deletion mutation was generated using a seamless clone kit. The expression of ADAR1, EV-D68 VP1, and HPIV3 hemagglutinin-neuraminidase (HN) proteins was identified using western blotting. The median tissue culture infectious dose (TCID<sub>50</sub>) was applied to detect viral titers. The transcription level of EV-D68 mRNA was analyzed using reverse transcription-quantitative PCR (RT-qPCR) and the viral 5'-untranslated region (5'-UTR)-mediated translation was analyzed using a dual luciferase reporter system.</AbstractText><AbstractText Label="CONCLUSION">We found that the transcription and expression of ADAR1 was inhibited upon EV-D68 infection. RNA interference of endogenous ADAR1 decreased VP1 protein expression and viral titers, while overexpression of ADAR1p110, but not ADAR1p150, facilitated viral replication. Immunofluorescence assays showed that ADAR1p110 migrated from the nucleus to the cytoplasm after EV-D68 infection. Further, ADAR1p110 lost its pro-viral ability after mutations of the active sites in the deaminase domain, and 5'-UTR sequencing of the viral genome revealed that ADAR1p110 likely plays a role in EV-D68 RNA editing. In addition, after ADAR1 knockdown, the levels of both phosphorylated double-stranded&#xa0;RNA dependent&#xa0;protein&#xa0;kinase (p-PKR) and phosphorylated eukaryotic initiation factor 2&#x3b1; (p-eIF2&#x3b1;) increased. Attenuated translation activity of the viral genome 5'-UTR was also observed in the dual-luciferase reporter assay. Lastly, the deletion of ADAR1p110 dsRBDs increased the level of p-PKR, which correlated with a decreased VP1 expression, indicating that the promotion of EV-D68 replication by ADAR1p110 is also related to the inhibition of PKR activation by its dsRBDs. Our study illustrates that ADAR1p110 is a novel pro-viral factor of EV-D68 replication and provides a theoretical basis for EV-D68 antiviral research.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Zhang</LastName><ForeName>Kehan</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Pathogen Biology and Immunology Laboratory and Laboratory of Tissue and Cell Biology, Experimental Teaching and Management Center, Chongqing Medical University, Chongqing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of the First Clinical Medicine, Chongqing Medical University, Chongqing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Wang</LastName><ForeName>Siyuan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of the First Clinical Medicine, Chongqing Medical University, Chongqing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Chen</LastName><ForeName>Tingting</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Pathogen Biology and Immunology Laboratory and Laboratory of Tissue and Cell Biology, Experimental Teaching and Management Center, Chongqing Medical University, Chongqing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tu</LastName><ForeName>Zeng</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Pathogen Biology, Basic Medical School, Chongqing Medical University, Chongqing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Xia</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of the First Clinical Medicine, Chongqing Medical University, Chongqing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zang</LastName><ForeName>Guangchao</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Pathogen Biology and Immunology Laboratory and Laboratory of Tissue and Cell Biology, Experimental Teaching and Management Center, Chongqing Medical University, Chongqing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Chun</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Chongqing Better Biotechnology LLC, Chongqing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fan</LastName><ForeName>Xinyue</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of the First Clinical Medicine, Chongqing Medical University, Chongqing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Jia</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Pathogen Biology and Immunology Laboratory and Laboratory of Tissue and Cell Biology, Experimental Teaching and Management Center, Chongqing Medical University, Chongqing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tian</LastName><ForeName>Yunbo</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Quality Management Section, Chongqing Blood Center, Chongqing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cheng</LastName><ForeName>Yong</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Monitoring On Terrestrial Wildlife-Borne Infectious Diseases, Jinggangshan National Nature Reserve of Jiangxi Province, Ji'an, Jiangxi, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lu</LastName><ForeName>Nan</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Pathogen Biology, Basic Medical School, Chongqing Medical University, Chongqing, China. ficus@cqmu.edu.cn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Guangyuan</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Pathogen Biology and Immunology Laboratory and Laboratory of Tissue and Cell Biology, Experimental Teaching and Management Center, Chongqing Medical University, Chongqing, China. sanqinyouthzhang@126.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>12</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Virol J</MedlineTA><NlmUniqueID>101231645</NlmUniqueID><ISSNLinking>1743-422X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012330">RNA, Double-Stranded</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006367" MajorTopicYN="N">HeLa Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D030016" MajorTopicYN="Y">Enterovirus D, Human</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014779" MajorTopicYN="N">Virus Replication</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012330" MajorTopicYN="N">RNA, Double-Stranded</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="Y">Enterovirus Infections</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ADAR1p110</Keyword><Keyword MajorTopicYN="N">Deaminase domain</Keyword><Keyword MajorTopicYN="N">EV-D68</Keyword><Keyword MajorTopicYN="N">PKR</Keyword><Keyword MajorTopicYN="N">dsRBDs</Keyword></KeywordList><CoiStatement>The authors declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>6</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>12</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>12</Month><Day>22</Day><Hour>23</Hour><Minute>51</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>12</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>12</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>12</Month><Day>22</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36550502</ArticleId><ArticleId IdType="pmc">PMC9773460</ArticleId><ArticleId IdType="doi">10.1186/s12985-022-01952-6</ArticleId><ArticleId IdType="pii">10.1186/s12985-022-01952-6</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Khan F. Enterovirus D68: acute respiratory illness and the 2014 outbreak. Emerg Med Clin North Am. 2015;33(2):e19&#x2013;32. doi: 10.1016/j.emc.2014.12.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.emc.2014.12.011</ArticleId><ArticleId IdType="pubmed">26065305</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang W, Wang G, Zhuge J, Nolan SM, Dimitrova N, Fallon JT. Whole-genome sequence analysis reveals the enterovirus D68 Isolates during the United States 2014 Outbreak Mainly Belong to a Novel Clade. Sci Rep. 2015;5:15223. doi: 10.1038/srep15223.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep15223</ArticleId><ArticleId IdType="pmc">PMC4606740</ArticleId><ArticleId IdType="pubmed">26469882</ArticleId></ArticleIdList></Reference><Reference><Citation>Cross ST, Michalski D, Miller MR, Wilusz J. RNA regulatory processes in RNA virus biology. Wiley Interdiscip Rev RNA. 2019;10(5):e1536. doi: 10.1002/wrna.1536.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/wrna.1536</ArticleId><ArticleId IdType="pmc">PMC6697219</ArticleId><ArticleId IdType="pubmed">31034160</ArticleId></ArticleIdList></Reference><Reference><Citation>Oberste MS, Maher K, Schnurr D, Flemister MR, Lovchik JC, Peters H, et al. Enterovirus 68 is associated with respiratory illness and shares biological features with both the enteroviruses and the rhinoviruses. J Gen Virol. 2004;85(Pt 9):2577&#x2013;2584. doi: 10.1099/vir.0.79925-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.79925-0</ArticleId><ArticleId IdType="pubmed">15302951</ArticleId></ArticleIdList></Reference><Reference><Citation>Waghmare A, Pergam SA, Jerome KR, Englund JA, Boeckh M, Kuypers J. Clinical disease due to enterovirus D68 in adult hematologic malignancy patients and hematopoietic cell transplant recipients. Blood. 2015;125(11):1724&#x2013;1729. doi: 10.1182/blood-2014-12-616516.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2014-12-616516</ArticleId><ArticleId IdType="pmc">PMC4357580</ArticleId><ArticleId IdType="pubmed">25593338</ArticleId></ArticleIdList></Reference><Reference><Citation>Helfferich J, Knoester M, Van Leer-Buter CC, Neuteboom RF, Meiners LC, Niesters HG, et al. Acute flaccid myelitis and enterovirus D68: lessons from the past and present. Eur J Pediatr. 2019;178(9):1305&#x2013;1315. doi: 10.1007/s00431-019-03435-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00431-019-03435-3</ArticleId><ArticleId IdType="pmc">PMC6694036</ArticleId><ArticleId IdType="pubmed">31338675</ArticleId></ArticleIdList></Reference><Reference><Citation>Bass BL, Weintraub H. An unwinding activity that covalently modifies its double-stranded RNA substrate. Cell. 1988;55(6):1089&#x2013;1098. doi: 10.1016/0092-8674(88)90253-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0092-8674(88)90253-X</ArticleId><ArticleId IdType="pubmed">3203381</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishikura K. A-to-I editing of coding and non-coding RNAs by ADARs. Nat Rev Mol Cell Biol. 2016;17(2):83&#x2013;96. doi: 10.1038/nrm.2015.4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrm.2015.4</ArticleId><ArticleId IdType="pmc">PMC4824625</ArticleId><ArticleId IdType="pubmed">26648264</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang W, Chendrimada TP, Wang Q, Higuchi M, Seeburg PH, Shiekhattar R, et al. Modulation of microRNA processing and expression through RNA editing by ADAR deaminases. Nat Struct Mol Biol. 2006;13(1):13&#x2013;21. doi: 10.1038/nsmb1041.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nsmb1041</ArticleId><ArticleId IdType="pmc">PMC2950615</ArticleId><ArticleId IdType="pubmed">16369484</ArticleId></ArticleIdList></Reference><Reference><Citation>Bass BL. Double-stranded RNA as a template for gene silencing. Cell. 2000;101(3):235&#x2013;238. doi: 10.1016/S0092-8674(02)71133-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0092-8674(02)71133-1</ArticleId><ArticleId IdType="pubmed">10847677</ArticleId></ArticleIdList></Reference><Reference><Citation>Hur S. Double-stranded RNA Sensors and modulators in innate immunity. In: Yokoyama WM, editor. Annual Review of Immunology, Vol 37, 2019. Annual Review of Immunology. 372019. p. 349&#x2013;75.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7136661</ArticleId><ArticleId IdType="pubmed">30673536</ArticleId></ArticleIdList></Reference><Reference><Citation>Bass BL. RNA editing by adenosine deaminases that act on RNA. Annu Rev Biochem. 2002;71:817&#x2013;846. doi: 10.1146/annurev.biochem.71.110601.135501.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.biochem.71.110601.135501</ArticleId><ArticleId IdType="pmc">PMC1823043</ArticleId><ArticleId IdType="pubmed">12045112</ArticleId></ArticleIdList></Reference><Reference><Citation>Cattaneo R, Billeter MA. Mutations and A/I hypermutations in measles virus persistent infections. Curr Top Microbiol Immunol. 1992;176:63&#x2013;74.</Citation><ArticleIdList><ArticleId IdType="pubmed">1600755</ArticleId></ArticleIdList></Reference><Reference><Citation>Ivanov A, Memczak S, Wyler E, Torti F, Porath HT, Orejuela MR, et al. Analysis of intron sequences reveals hallmarks of circular RNA biogenesis in animals. Cell Rep. 2015;10(2):170&#x2013;177. doi: 10.1016/j.celrep.2014.12.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2014.12.019</ArticleId><ArticleId IdType="pubmed">25558066</ArticleId></ArticleIdList></Reference><Reference><Citation>de Chassey B, Aublin-Gex A, Ruggieri A, Meyniel-Schicklin L, Pradezynski F, Davoust N, et al. The interactomes of influenza virus NS1 and NS2 proteins identify new host factors and provide insights for ADAR1 playing a supportive role in virus replication. PLoS Pathog. 2013;9(7):e1003440. doi: 10.1371/journal.ppat.1003440.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1003440</ArticleId><ArticleId IdType="pmc">PMC3701712</ArticleId><ArticleId IdType="pubmed">23853584</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan L, Jia Q, Yang S, Idris NFB, Li Y, Wang Y, et al. ADAR1 promotes HBV replication through its deaminase domain. Front Biosci (Landmark Ed) 2020;25:710&#x2013;721. doi: 10.2741/4830.</Citation><ArticleIdList><ArticleId IdType="doi">10.2741/4830</ArticleId><ArticleId IdType="pubmed">31585913</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou S, Yang C, Zhao F, Huang Y, Lin Y, Huang C, et al. Double-stranded RNA deaminase ADAR1 promotes the Zika virus replication by inhibiting the activation of protein kinase PKR. J Biol Chem. 2019;294(48):18168&#x2013;18180. doi: 10.1074/jbc.RA119.009113.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.RA119.009113</ArticleId><ArticleId IdType="pmc">PMC6885634</ArticleId><ArticleId IdType="pubmed">31636123</ArticleId></ArticleIdList></Reference><Reference><Citation>Clerzius G, Gelinas JF, Gatignol A. Multiple levels of PKR inhibition during HIV-1 replication. Rev Med Virol. 2011;21(1):42&#x2013;53. doi: 10.1002/rmv.674.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.674</ArticleId><ArticleId IdType="pubmed">21294215</ArticleId></ArticleIdList></Reference><Reference><Citation>Dong N, Dong C, Xiong S. Janus effects of ADAR1 on CVB3-induced viral myocarditis at different infection stages. Int J Cardiol. 2016;223:898&#x2013;905. doi: 10.1016/j.ijcard.2016.08.315.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcard.2016.08.315</ArticleId><ArticleId IdType="pubmed">27584568</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan L, Jia Q, Yang S, Idris NFB, Li Y, Wang Y, et al. ADAR1 promotes HBV replication through its deaminase domain. Front Biosci (Landmark Ed) 2020;25(4):710&#x2013;721. doi: 10.2741/4830.</Citation><ArticleIdList><ArticleId IdType="doi">10.2741/4830</ArticleId><ArticleId IdType="pubmed">31585913</ArticleId></ArticleIdList></Reference><Reference><Citation>Engler C, Gruetzner R, Kandzia R, Marillonnet S. Golden gate shuffling: a one-pot DNA shuffling method based on type IIs restriction enzymes. PLoS ONE. 2009;4(5):e5553. doi: 10.1371/journal.pone.0005553.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0005553</ArticleId><ArticleId IdType="pmc">PMC2677662</ArticleId><ArticleId IdType="pubmed">19436741</ArticleId></ArticleIdList></Reference><Reference><Citation>Engler C, Kandzia R, Marillonnet S. A one pot, one step, precision cloning method with high throughput capability. PLoS ONE. 2008;3(11):e3647. doi: 10.1371/journal.pone.0003647.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0003647</ArticleId><ArticleId IdType="pmc">PMC2574415</ArticleId><ArticleId IdType="pubmed">18985154</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakahama T, Kato Y, Shibuya T, Inoue M, Kim JI, Vongpipatana T, et al. Mutations in the adenosine deaminase ADAR1 that prevent endogenous Z-RNA binding induce Aicardi-Goutieres-syndrome-like encephalopathy. Immunity. 2021;54(9):1976&#x2013;88 e7. doi: 10.1016/j.immuni.2021.08.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2021.08.022</ArticleId><ArticleId IdType="pubmed">34525338</ArticleId></ArticleIdList></Reference><Reference><Citation>Galipon J, Ishii R, Ishiguro S, Suzuki Y, Kondo S, Okada-Hatakeyama M, et al. High-quality overlapping paired-end reads for the detection of A-to-I editing on small RNA. Methods Mol Biol. 2018;1823:167&#x2013;183. doi: 10.1007/978-1-4939-8624-8_13.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-4939-8624-8_13</ArticleId><ArticleId IdType="pubmed">29959681</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai F, Drakas R, Nishikura K. Mutagenic analysis of double-stranded RNA adenosine deaminase, a candidate enzyme for RNA editing of glutamate-gated ion channel transcripts. J Biol Chem. 1995;270(29):17098&#x2013;17105. doi: 10.1074/jbc.270.29.17098.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.270.29.17098</ArticleId><ArticleId IdType="pubmed">7615504</ArticleId></ArticleIdList></Reference><Reference><Citation>Clerzius G, Gelinas JF, Daher A, Bonnet M, Meurs EF, Gatignol A. ADAR1 interacts with PKR during human immunodeficiency virus infection of lymphocytes and contributes to viral replication. J Virol. 2009;83(19):10119&#x2013;10128. doi: 10.1128/JVI.02457-08.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02457-08</ArticleId><ArticleId IdType="pmc">PMC2747994</ArticleId><ArticleId IdType="pubmed">19605474</ArticleId></ArticleIdList></Reference><Reference><Citation>Nie Y, Hammond GL, Yang JH. Double-stranded RNA deaminase ADAR1 increases host susceptibility to virus infection. J Virol. 2007;81(2):917&#x2013;923. doi: 10.1128/JVI.01527-06.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01527-06</ArticleId><ArticleId IdType="pmc">PMC1797455</ArticleId><ArticleId IdType="pubmed">17079286</ArticleId></ArticleIdList></Reference><Reference><Citation>Song B, Shiromoto Y, Minakuchi M, Nishikura K. The role of RNA editing enzyme ADAR1 in human disease. Wiley Interdiscip Rev RNA. 2022;13(1):e1665. doi: 10.1002/wrna.1665.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/wrna.1665</ArticleId><ArticleId IdType="pmc">PMC8651834</ArticleId><ArticleId IdType="pubmed">34105255</ArticleId></ArticleIdList></Reference><Reference><Citation>Gelinas JF, Clerzius G, Shaw E, Gatignol A. Enhancement of replication of RNA viruses by ADAR1 via RNA editing and inhibition of RNA-activated protein kinase. J Virol. 2011;85(17):8460&#x2013;8466. doi: 10.1128/JVI.00240-11.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00240-11</ArticleId><ArticleId IdType="pmc">PMC3165853</ArticleId><ArticleId IdType="pubmed">21490091</ArticleId></ArticleIdList></Reference><Reference><Citation>Toth AM, Li Z, Cattaneo R, Samuel CE. RNA-specific adenosine deaminase ADAR1 suppresses measles virus-induced apoptosis and activation of protein kinase PKR. J Biol Chem. 2009;284(43):29350&#x2013;29356. doi: 10.1074/jbc.M109.045146.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M109.045146</ArticleId><ArticleId IdType="pmc">PMC2785566</ArticleId><ArticleId IdType="pubmed">19710021</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang J, Pang Z, Zhou Z, Li X, Liu S, Cheng J, et al. Enterovirus D68 protease 2A(pro) Targets TRAF3 to subvert host innate immune responses. J Virol. 2021;95(3):e01987&#x2013;e2020. doi: 10.1128/JVI.01856-20.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01856-20</ArticleId><ArticleId IdType="pmc">PMC7925118</ArticleId><ArticleId IdType="pubmed">33148796</ArticleId></ArticleIdList></Reference><Reference><Citation>Rui Y, Su J, Wang H, Chang J, Wang S, Zheng W, et al. Disruption of MDA5-mediated innate immune responses by the 3C proteins of Coxsackievirus A16, COXSACKIEVIRUS A6, and Enterovirus D68. J Virol. 2017;91(13):17. doi: 10.1128/JVI.00546-17.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00546-17</ArticleId><ArticleId IdType="pmc">PMC5469270</ArticleId><ArticleId IdType="pubmed">28424289</ArticleId></ArticleIdList></Reference><Reference><Citation>Siering O, Cattaneo R, Pfaller CK. C proteins: controllers of orderly paramyxovirus replication and of the innate immune response. Viruses. 2022;14(1):137. doi: 10.3390/v14010137.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v14010137</ArticleId><ArticleId IdType="pmc">PMC8778822</ArticleId><ArticleId IdType="pubmed">35062341</ArticleId></ArticleIdList></Reference><Reference><Citation>Khadka S, Williams CG, Sweeney-Gibbons J, Basler CF. Marburg and Ebola virus mRNA 3' untranslated regions contain negative regulators of translation that are modulated by ADAR1 editing. J Virol. 2021;95(19):e0065221. doi: 10.1128/JVI.00652-21.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00652-21</ArticleId><ArticleId IdType="pmc">PMC8428382</ArticleId><ArticleId IdType="pubmed">34346762</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L, Sun Y, Song X, Wang Z, Zhang Y, Zhao Y, et al. Hepatitis B virus evades immune recognition via RNA adenosine deaminase ADAR1-mediated viral RNA editing in hepatocytes. Cell Mol Immunol. 2021;18(8):1871&#x2013;1882. doi: 10.1038/s41423-021-00729-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41423-021-00729-1</ArticleId><ArticleId IdType="pmc">PMC8322072</ArticleId><ArticleId IdType="pubmed">34253859</ArticleId></ArticleIdList></Reference><Reference><Citation>Ringlander J, Fingal J, Kann H, Prakash K, Rydell G, Andersson M, et al. Impact of ADAR-induced editing of minor viral RNA populations on replication and transmission of SARS-CoV-2. Proc Natl Acad Sci U S A. 2022;119(6):112663119. doi: 10.1073/pnas.2112663119.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2112663119</ArticleId><ArticleId IdType="pmc">PMC8833170</ArticleId><ArticleId IdType="pubmed">35064076</ArticleId></ArticleIdList></Reference><Reference><Citation>Murphy DG, Dimock K, Kang CY. Numerous transitions in human parainfluenza virus 3 RNA recovered from persistently infected cells. Virology. 1991;181(2):760&#x2013;763. doi: 10.1016/0042-6822(91)90913-V.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0042-6822(91)90913-V</ArticleId><ArticleId IdType="pubmed">1849685</ArticleId></ArticleIdList></Reference><Reference><Citation>Valente L, Nishikura K. RNA binding-independent dimerization of adenosine deaminases acting on RNA and dominant negative effects of nonfunctional subunits on dimer functions. J Biol Chem. 2007;282(22):16054&#x2013;16061. doi: 10.1074/jbc.M611392200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M611392200</ArticleId><ArticleId IdType="pmc">PMC2954279</ArticleId><ArticleId IdType="pubmed">17428802</ArticleId></ArticleIdList></Reference><Reference><Citation>Pfaller CK, Donohue RC, Nersisyan S, Brodsky L, Cattaneo R. Extensive editing of cellular and viral double-stranded RNA structures accounts for innate immunity suppression and the proviral activity of ADAR1p150. PLoS Biol. 2018;16(11):e2006577. doi: 10.1371/journal.pbio.2006577.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pbio.2006577</ArticleId><ArticleId IdType="pmc">PMC6264153</ArticleId><ArticleId IdType="pubmed">30496178</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>